Candriam SCA’s Teladoc Health TDOC Stock Holding History

Candriam SCA’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-39,019	Closed	-$930K	–	857
2023 Q1	$930K	Sell	39,019 -15,560	-29%	-$416K	0.01%	708
2022 Q4	$1.29M	Sell	54,579 -26,836	-33%	-$724K	0.01%	662
2022 Q3	$2.06M	Buy	81,415 +45,675	+128%	+$1.6M	0.01%	577
2022 Q2	$1.19M	Sell	35,740 -7,640	-18%	-$325K	0.01%	602
2022 Q1	$3.13M	Buy	43,380 +3,835	+10%	+$276K	0.02%	447
2021 Q4	$3.63M	Sell	39,545 -2,585	-6%	-$309K	0.02%	423
2021 Q3	$5.34M	Buy	42,130 +4,206	+11%	+$612K	0.04%	388
2021 Q2	$6.31M	Buy	37,924 +10,890	+40%	+$1.76M	0.04%	362
2021 Q1	$5.19M	Hold	27,034	–	–	0.04%	367
2020 Q4	$5.41M	Buy	27,034 +14,212	+111%	+$2.89M	0.04%	376
2020 Q3	$2.81M	Buy	12,822 +3,780	+42%	+$800K	0.03%	448
2020 Q2	$2.83M	Buy	+9,042	New	+$1.58M	0.03%	432

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SOMRS

State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Candriam SCA's TDOC Position: Q2 2023 in Review

Candriam SCA sold out of Teladoc Health (TDOC) in Q2 2023, closing a stake of 39,019 shares — an estimated $930K sold.

Candriam SCA first reported a position in TDOC in Q2 2020 and held it in 12 quarters. The position peaked at $6.31M in Q2 2021. 431 funds tracked by Wall St. Rank hold TDOC as of Q2 2023.

Candriam SCA reported no remaining Teladoc Health position as of Q2 2023 after selling out during the quarter.
Candriam SCA sold 39,019 Teladoc Health shares in Q2 2023, an estimated $930K.
Candriam SCA first reported a position in Teladoc Health in Q2 2020 and held it in 12 quarters.
Candriam SCA's Teladoc Health position peaked at $6.31M in Q2 2021.
431 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2023.

Based on Candriam SCA's 13F filing for Q2 2023, filed 8 Aug 2023.